The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...
While weight-loss drugs like Zepbound (LLY) and Wegovy (NVO) offer significant health benefits, their high costs make them ...
The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...
Opko Health and Entera Bio entered into a collaboration and license agreement to advance a tablet aimed at addressing obesity, metabolic and fibrotic disorders.
According to the Association’s 2025 Statistics Update: ...
Many people who have struggled with their weight have been told to “eat less and move more.” Others have spent years juggling ...
Fortunately, with President Trump’s leadership on the issue, he can turn the tide in the quest to end obesity. There’s a ...
Diabetes and obesity remain at the top of the state's health issues.
Sociologist Jessica Calarco explains why the right keeps winning, and how progressive narratives can turn the tide ...
The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...
Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive
Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback